DBV Technologies (DBVT) Institutional Ownership
13F filers reported holding 39.6% of DBV Technologies (DBVT) shares as of Sep 30, 2026, across 87 filers.
- Held by 13F filers
- 39.6%
- Sep 30, 2026
- 13F filers
- 87
- quarter ended Sep 30, 2026
- 13F value
- $293.0M
- 24.9M shares
- Quarter's fund flow
- Mild distribution
- 8 new · 22 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Mohideen Pharis | Chief Medical Officer | Disposed · Open-market sale | 464 | $2.70 | ↗ |
| Jan 29, 2026 | Mohideen Pharis | Chief Medical Officer | Disposed · Open-market sale | 534 | $4.86 | ↗ |
| Jan 12, 2026 | BAKER BROS. ADVISORS LP | director | Disposed · Option exercise | 2,299,656BS Warrant | — | ↗ |
| Jan 12, 2026 | BAKER BROS. ADVISORS LP | director | Disposed · Option exercise | 25,005,240BS Warrant | — | ↗ |
| Jan 12, 2026 | BAKER BROS. ADVISORS LP | director | Acquired · Option exercise | 2,299,656Second Pre-Funded Warrant | — | ↗ |
| Jan 12, 2026 | BAKER BROS. ADVISORS LP | director | Acquired · Option exercise | 25,005,240Second Pre-Funded Warrant | — | ↗ |
| Dec 18, 2025 | EPIC Bpifrance | other | Disposed · Open-market sale | 1,292,103 | $4.19 | ↗ |
| Dec 17, 2025 | EPIC Bpifrance | other | Disposed · Open-market sale | 2,036,990 | $4.84 | ↗ |
| Dec 17, 2025 | EPIC Bpifrance | other | Disposed · Open-market sale | 40,000 | $5.28 | ↗ |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Disposed · Open-market sale | 1,624 | $2.77 | ↗ |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Acquired · Grant / award | 44,000 | — | ↗ |
| Nov 21, 2025 | Mohideen Pharis | Chief Medical Officer | Acquired · Grant / award | 253,000Employee Stock Option (right to buy) | — | ↗ |
| Nov 21, 2025 | Boucinha Virginie | Chief Financial Officer | Acquired · Grant / award | 32,000 | — | ↗ |
| Nov 21, 2025 | Boucinha Virginie | Chief Financial Officer | Acquired · Grant / award | 192,000Employee Stock Option (right to buy) | — | ↗ |
| Nov 21, 2025 | Trapp Kevin Michael | Chief Commercial Officer | Acquired · Grant / award | 55,000 | — | ↗ |
| Nov 21, 2025 | Trapp Kevin Michael | Chief Commercial Officer | Acquired · Grant / award | 316,250Employee Stock Option (right to buy) | — | ↗ |
| Nov 21, 2025 | Tasse Daniel | CHIEF EXECUTIVE OFFICER | Acquired · Grant / award | 964,000Employee Stock Option (right to buy) | — | ↗ |
| Nov 20, 2025 | Mohideen Pharis | Chief Medical Officer | Disposed · Open-market sale | 6,496 | $2.88 | ↗ |
| Jul 29, 2025 | Mohideen Pharis | Chief Medical Officer | Disposed · Open-market sale | 464 | $2.22 | ↗ |
| May 22, 2025 | Mohideen Pharis | Chief Medical Officer | Disposed · Open-market sale | 397 | $1.84 | ↗ |
* Holdings as reported for Sep 30, 2026, 51 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of DBV Technologies do institutions hold?
13F filers reported holding 39.6% of DBV Technologies' shares as of Sep 30, 2026, across 87 filers.
How many 13F filers hold DBV Technologies?
DBV Technologies was held by 87 13F filers as of Sep 30, 2026.
Not investment advice.

